학술논문

525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S462-S463
Subject
Language
ISSN
0923-7534